Global Strategies and Growth, One Vision for Transforming Healthcare.
BIG Global Strategy
Expertise
Why BIG Global
At BIG Global, we empower clients with strategic clarity, delivering actionable insights grounded in a deep understanding of international market dynamics. Our expertise enables confident decision-making as we proactively identify opportunities and mitigate global risks. From regulatory readiness to risk navigation, we provide the frameworks for seamless market entry and sustained growth. With a forward-looking approach, we align your strategies with evolving trends, ensuring you're competitive and leading. Our guidance transforms complexity into clarity—positioning your organization for long-term success across borders.
Our Proven Approach
We don’t just offer insight—we deliver a clear path forward. Our approach begins with deep market discovery, identifying the best-fit regions for your goals. From there, we develop tailored strategies covering competitive positioning, product localization, pricing models, and partnership planning. With hands-on support through every stage—from regulatory preparation to post-launch performance tracking—we help you confidently move. Whether you're entering a single region or scaling globally, our process reduces risk, accelerates growth, and ensures lasting impact in every market you touch.
Strategic Global Solutions
Global Vision Analysis
_edited.jpg)
Global Market Research
Global Vision Analysis offers expert counseling services to guide you in new markets. Our thorough analysis assesses your company's strengths and areas for development, ensuring you're prepared for international expansion.
We provide strategic market research to guide businesses in entering international markets successfully. Our services include comprehensive PESTLE and SWOT analyses, competitor benchmarking, and cultural adaptability assessments.
_edited_edited.jpg)
Global Strategic Planning
Our strategic planning services for global expansion are tailored to meet the unique needs of medical technology companies. From crafting market entry strategies to identifying growth opportunities, we provide a roadmap for navigating complex international markets.
.png)
Global Expansion: Strategic Insights
At BIG Global, we combine global market expertise with deep industry knowledge to create tailored strategies for medical technology companies expanding into international markets. These scenarios reflect our methodology and expertise, helping clients understand how we address complex global expansion processes.
_edited_edited_edited.jpg)
Global Market Analysis
Our global market analysis service offers comprehensive market audits designed thoroughly for your current market strategy efforts.
.png)
EXPO Representation
We understand the value of a growing presence at relevant trade shows. We are experts in marketers who specialize in increasing your company's visibility and improving the overall experience of attending a trade show.
_edited.jpg)
Risk Analysis
_edited.jpg)
Industries
BIG Global partners with innovative medical technology companies across diverse industries, providing tailored global expansion strategies to help them reach international markets.
Our risk mitigation services focus on analyzing economic, regulatory, and competitive risks, providing strategies to navigate uncertainties and ensure smooth operations. Clients achieve a competitive advantage with insights to outperform competitors and seize untapped opportunities.
Defining What’s Next in Global Health & MedTech.
Together, these sectors represent the future of global health—powered by technology, guided by data, and driven by strategic investment.
Chronic diseases now account for 75% of global deaths, placing immense pressure on health systems and projecting an 8% rise in inpatient hospital days over the next decade. This underscores the critical need for scalable and sustainable long-term care innovations.
In maternal and child health, digital tools are transforming care across the maternal-fetal spectrum. Initiatives like mass antibiotic distribution have led to a 14% reduction in child mortality in high-risk regions, demonstrating the life-saving impact of targeted innovation.
Telemedicine saw a 3000% increase in usage during the pandemic and continues to play a vital role in care delivery, with 22% of adults still using it monthly—proving its permanence as a global healthcare solution.
Surgical innovation is advancing rapidly with the rise of AI and robotic-assisted technologies, improving surgical precision, reducing recovery times, and enhancing overall system efficiency.
In infectious disease control, the integration of telemedicine and remote monitoring is revolutionizing care for patients with conditions like HIV, hepatitis C, and tuberculosis while strengthening global health preparedness.
The next frontier in global health isn't just innovation- it's access. Companies that anticipate emerging needs and build inclusive, cross-border solutions will define the future of MedTech."
-Tasha M. Jordan ICSO, CGBP, Founder
Research-Driven Decisions. Borderless Growth.
Data-Driven Decision Making: Gain access to precise, reliable data that helps identify growth opportunities and reduce uncertainty.
Risk Mitigation: Understand potential risks, from regulatory challenges to cultural barriers, ensuring a smoother market entry.
Competitive Edge: Stay ahead of competitors by identifying gaps and trends in the target market.
Enhanced Resource Allocation: Strategically allocate resources by focusing on high-potential opportunities and minimizing waste.
Long-Term Growth: Build a foundation for sustainable success in international markets by aligning strategies with local market dynamics.
Numbers that Navigate New Markets
Emerging Market Potential: Regions such as Asia-Pacific, Latin America, the Middle East, and Africa are experiencing growth rates between 7.3% and 8.8%, offering lucrative expansion opportunities.
Projected Market Growth: The global medical devices market is projected to grow from USD 542.21 billion in 2024 to USD 886.80 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.3%.
“MedTech companies with global operations generate up to 45.5% of their revenue internationally — leveraging diversification for a competitive edge and higher profitability.”
High-Growth Market Segments: Approximately 25% of the MedTech market is projected to grow 6% annually from 2022 to 2025, indicating substantial opportunities in these segments.
"EBITDA margins in MedTech average 22%, outperforming industries like automotive and industrials (below 10%)."
Chronic diseases cause 75% of global deaths, with hospital stays projected to rise 8% in the next decade. Telemedicine and remote monitoring are improving care for infectious diseases like HIV and hepatitis C, while AI and robotic-assisted surgery are enhancing precision and recovery in surgical care. Telehealth use remains strong, with 22% of adults using it monthly post-pandemic. In maternal and child health, digital tools and mass antibiotic efforts have reduced child mortality by 14% in high-risk areas.
Industries We Serve
Accelerating Global Impact Across the World’s Most Vital Healthcare Sectors.
-
Chronic Disease Management
-
Infectious Disease Control
-
Aging Population & Home Medical Equipment
-
Maternal & Child Health
-
Surgical Innovations
-
Telemedicine & Remote Patient Monitoring
-
Medical Device Manufacturing
Ready to Expand Globally with Confidence?
Let BIG Global help unlock new opportunities, reduce risks, and build a customized strategy for sustainable international growth.
📩 Contact Us Today to schedule your consultation and discover how we can help you succeed globally.
Let’s Build Your Global Success Story Together.